Brief: GenSight Biologics FY EPS EUR -0.08
27/03/2026 06:30
Mar 27 (Reuters) - GenSight Biologics FY net income EUR -12 million.
Recent news on Gensight Biologics SA
See all newsHealth Rounds: Blindness treatment based on Nobel-winning research shows promise
France's GenSight Biologics H1 net loss widens on higher R&D expenses
Brief: GenSight Biologics H1 Net Income EUR -10.3 Million
France's GenSight Biologics 2025 net loss narrows on reduced R&D spending
Brief: GenSight Biologics FY EPS EUR -0.08